Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide
0.1.0 - ci-build
Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide
0.1.0 - ci-build
Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide, published by Digital Health Agency (DHA), Kenya. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/IntelliSOFT-Consulting/nccpFHIRIG/ and changes regularly. See the Directory of published versions
| Active as of 2026-06-04 |
<CodeSystem xmlns="http://hl7.org/fhir">
<id value="sha-interventions-cs"/>
<language value="en"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: CodeSystem sha-interventions-cs</b></p><a name="sha-interventions-cs"> </a><a name="hcsha-interventions-cs"> </a><p>This case-sensitive code system <code>https://nshr-uat.sha.go.ke/fhir/CodeSystem/sha-interventions-cs</code> defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style="white-space:nowrap">SHA-CHEMO-FIRST-LINE<a name="sha-interventions-cs-SHA-CHEMO-FIRST-LINE"> </a></td><td>SHA: Chemotherapy — First Line</td><td>First-line chemotherapy regimen.</td></tr><tr><td style="white-space:nowrap">SHA-CHEMO-SECOND-LINE<a name="sha-interventions-cs-SHA-CHEMO-SECOND-LINE"> </a></td><td>SHA: Chemotherapy — Second Line</td><td>Second-line or salvage chemotherapy.</td></tr><tr><td style="white-space:nowrap">SHA-CHEMO-ADJUVANT<a name="sha-interventions-cs-SHA-CHEMO-ADJUVANT"> </a></td><td>SHA: Chemotherapy — Adjuvant</td><td>Post-surgery adjuvant chemotherapy.</td></tr><tr><td style="white-space:nowrap">SHA-CHEMO-NEO-ADJUVANT<a name="sha-interventions-cs-SHA-CHEMO-NEO-ADJUVANT"> </a></td><td>SHA: Chemotherapy — Neo-adjuvant</td><td>Pre-surgery neo-adjuvant chemotherapy.</td></tr><tr><td style="white-space:nowrap">SHA-CHEMO-PALLIATIVE<a name="sha-interventions-cs-SHA-CHEMO-PALLIATIVE"> </a></td><td>SHA: Chemotherapy — Palliative</td><td>Palliative intent chemotherapy.</td></tr><tr><td style="white-space:nowrap">SHA-RT-RADICAL<a name="sha-interventions-cs-SHA-RT-RADICAL"> </a></td><td>SHA: Radiotherapy — Radical</td><td>Curative radiotherapy course.</td></tr><tr><td style="white-space:nowrap">SHA-RT-PALLIATIVE<a name="sha-interventions-cs-SHA-RT-PALLIATIVE"> </a></td><td>SHA: Radiotherapy — Palliative</td><td>Palliative radiotherapy course.</td></tr><tr><td style="white-space:nowrap">SHA-RT-ADJUVANT<a name="sha-interventions-cs-SHA-RT-ADJUVANT"> </a></td><td>SHA: Radiotherapy — Adjuvant</td><td>Post-surgery adjuvant radiotherapy.</td></tr><tr><td style="white-space:nowrap">SHA-RT-CONCURRENT-CRT<a name="sha-interventions-cs-SHA-RT-CONCURRENT-CRT"> </a></td><td>SHA: Concurrent Chemo-Radiotherapy</td><td>Chemotherapy and radiotherapy delivered concurrently.</td></tr><tr><td style="white-space:nowrap">SHA-SURGERY-CURATIVE<a name="sha-interventions-cs-SHA-SURGERY-CURATIVE"> </a></td><td>SHA: Surgery — Curative</td><td>Cancer surgery with curative intent.</td></tr><tr><td style="white-space:nowrap">SHA-SURGERY-PALLIATIVE<a name="sha-interventions-cs-SHA-SURGERY-PALLIATIVE"> </a></td><td>SHA: Surgery — Palliative</td><td>Palliative or debulking surgery.</td></tr><tr><td style="white-space:nowrap">SHA-BMT-AUTOLOGOUS<a name="sha-interventions-cs-SHA-BMT-AUTOLOGOUS"> </a></td><td>SHA: BMT — Autologous</td><td>Autologous bone marrow / stem cell transplant.</td></tr><tr><td style="white-space:nowrap">SHA-BMT-ALLOGENEIC<a name="sha-interventions-cs-SHA-BMT-ALLOGENEIC"> </a></td><td>SHA: BMT — Allogeneic</td><td>Allogeneic bone marrow / stem cell transplant.</td></tr><tr><td style="white-space:nowrap">SHA-HORMONAL-THERAPY<a name="sha-interventions-cs-SHA-HORMONAL-THERAPY"> </a></td><td>SHA: Hormonal Therapy</td><td>Hormone therapy for hormone-responsive cancers.</td></tr><tr><td style="white-space:nowrap">SHA-TARGETED-THERAPY<a name="sha-interventions-cs-SHA-TARGETED-THERAPY"> </a></td><td>SHA: Targeted Therapy</td><td>Targeted molecular therapy / immunotherapy.</td></tr><tr><td style="white-space:nowrap">SHA-SUPPORTIVE-CARE<a name="sha-interventions-cs-SHA-SUPPORTIVE-CARE"> </a></td><td>SHA: Supportive / Supportive Care</td><td>Supportive medications and G-CSF.</td></tr><tr><td style="white-space:nowrap">SHA-PAIN-MANAGEMENT<a name="sha-interventions-cs-SHA-PAIN-MANAGEMENT"> </a></td><td>SHA: Palliative Pain Management</td><td>Opioid and pain management for cancer.</td></tr><tr><td style="white-space:nowrap">SHA-CANCER-SCREENING<a name="sha-interventions-cs-SHA-CANCER-SCREENING"> </a></td><td>SHA: Cancer Screening</td><td>Covered cancer screening tests (cervical, breast).</td></tr><tr><td style="white-space:nowrap">SHA-BIOPSY<a name="sha-interventions-cs-SHA-BIOPSY"> </a></td><td>SHA: Diagnostic Biopsy</td><td>Tissue biopsy for cancer diagnosis.</td></tr><tr><td style="white-space:nowrap">SHA-IMAGING<a name="sha-interventions-cs-SHA-IMAGING"> </a></td><td>SHA: Oncology Diagnostic Imaging</td><td>CT, MRI, PET-CT for staging or response.</td></tr><tr><td style="white-space:nowrap">SHA-ONCOLOGY-CONSULT<a name="sha-interventions-cs-SHA-ONCOLOGY-CONSULT"> </a></td><td>SHA: Oncology Consultation</td><td>Specialist oncology consultation.</td></tr><tr><td style="white-space:nowrap">SHA-MDT<a name="sha-interventions-cs-SHA-MDT"> </a></td><td>SHA: MDT Meeting</td><td>Multidisciplinary tumour board review.</td></tr><tr><td style="white-space:nowrap">SHA-PATHOLOGY<a name="sha-interventions-cs-SHA-PATHOLOGY"> </a></td><td>SHA: Pathology / Histopathology</td><td>Histopathology, IHC, or molecular diagnostics.</td></tr><tr><td style="white-space:nowrap">SHA-RT-DOSE-PER-FRACTION<a name="sha-interventions-cs-SHA-RT-DOSE-PER-FRACTION"> </a></td><td>SHA: RT Dose Per Fraction</td><td>Radiation dose delivered per fraction (Gy).</td></tr><tr><td style="white-space:nowrap">SHA-RT-TOTAL-FRACTIONS<a name="sha-interventions-cs-SHA-RT-TOTAL-FRACTIONS"> </a></td><td>SHA: RT Total Fractions Delivered</td><td>Total number of radiation fractions delivered.</td></tr><tr><td style="white-space:nowrap">SHA-SUSPECTED-CANCER-TYPE<a name="sha-interventions-cs-SHA-SUSPECTED-CANCER-TYPE"> </a></td><td>SHA: Suspected Cancer Type</td><td>Type of cancer suspected at screening/referral.</td></tr><tr><td style="white-space:nowrap">SHA-SUSPICION-LEVEL<a name="sha-interventions-cs-SHA-SUSPICION-LEVEL"> </a></td><td>SHA: Cancer Suspicion Level</td><td>Clinical level of suspicion for malignancy.</td></tr><tr><td style="white-space:nowrap">SHA-REASON-FOR-SUSPICION<a name="sha-interventions-cs-SHA-REASON-FOR-SUSPICION"> </a></td><td>SHA: Reason for Suspicion</td><td>Reason underpinning the cancer suspicion.</td></tr><tr><td style="white-space:nowrap">SHA-PRESENTING-SYMPTOMS<a name="sha-interventions-cs-SHA-PRESENTING-SYMPTOMS"> </a></td><td>SHA: Presenting Symptoms</td><td>Symptoms presented by the patient.</td></tr><tr><td style="white-space:nowrap">SHA-DIAGNOSTIC-WORKUP<a name="sha-interventions-cs-SHA-DIAGNOSTIC-WORKUP"> </a></td><td>SHA: Planned Diagnostic Workup</td><td>Diagnostic investigations planned for confirmation.</td></tr></table></div>
</text>
<url
value="https://nshr-uat.sha.go.ke/fhir/CodeSystem/sha-interventions-cs"/>
<version value="0.1.0"/>
<name value="SHAInterventionsCS"/>
<title value="Kenya SHA Oncology Interventions Code System"/>
<status value="active"/>
<experimental value="false"/>
<date value="2026-06-04T14:49:30+00:00"/>
<publisher value="Digital Health Agency (DHA), Kenya"/>
<contact>
<name value="Digital Health Agency (DHA), Kenya"/>
<telecom>
<system value="url"/>
<value value="https://dha.go.ke"/>
</telecom>
<telecom>
<system value="email"/>
<value value="info@dha.go.ke"/>
</telecom>
</contact>
<contact>
<name value="Digital Health Agency Kenya – FHIR Team"/>
<telecom>
<system value="email"/>
<value value="info@dha.go.ke"/>
<use value="work"/>
</telecom>
<telecom>
<system value="url"/>
<value value="https://dha.go.ke"/>
<use value="work"/>
</telecom>
</contact>
<description
value="Social Health Authority (SHA) benefit package codes for oncology interventions."/>
<jurisdiction>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="KE"/>
<display value="Kenya"/>
</coding>
</jurisdiction>
<caseSensitive value="true"/>
<content value="complete"/>
<count value="30"/>
<concept>
<code value="SHA-CHEMO-FIRST-LINE"/>
<display value="SHA: Chemotherapy — First Line"/>
<definition value="First-line chemotherapy regimen."/>
</concept>
<concept>
<code value="SHA-CHEMO-SECOND-LINE"/>
<display value="SHA: Chemotherapy — Second Line"/>
<definition value="Second-line or salvage chemotherapy."/>
</concept>
<concept>
<code value="SHA-CHEMO-ADJUVANT"/>
<display value="SHA: Chemotherapy — Adjuvant"/>
<definition value="Post-surgery adjuvant chemotherapy."/>
</concept>
<concept>
<code value="SHA-CHEMO-NEO-ADJUVANT"/>
<display value="SHA: Chemotherapy — Neo-adjuvant"/>
<definition value="Pre-surgery neo-adjuvant chemotherapy."/>
</concept>
<concept>
<code value="SHA-CHEMO-PALLIATIVE"/>
<display value="SHA: Chemotherapy — Palliative"/>
<definition value="Palliative intent chemotherapy."/>
</concept>
<concept>
<code value="SHA-RT-RADICAL"/>
<display value="SHA: Radiotherapy — Radical"/>
<definition value="Curative radiotherapy course."/>
</concept>
<concept>
<code value="SHA-RT-PALLIATIVE"/>
<display value="SHA: Radiotherapy — Palliative"/>
<definition value="Palliative radiotherapy course."/>
</concept>
<concept>
<code value="SHA-RT-ADJUVANT"/>
<display value="SHA: Radiotherapy — Adjuvant"/>
<definition value="Post-surgery adjuvant radiotherapy."/>
</concept>
<concept>
<code value="SHA-RT-CONCURRENT-CRT"/>
<display value="SHA: Concurrent Chemo-Radiotherapy"/>
<definition
value="Chemotherapy and radiotherapy delivered concurrently."/>
</concept>
<concept>
<code value="SHA-SURGERY-CURATIVE"/>
<display value="SHA: Surgery — Curative"/>
<definition value="Cancer surgery with curative intent."/>
</concept>
<concept>
<code value="SHA-SURGERY-PALLIATIVE"/>
<display value="SHA: Surgery — Palliative"/>
<definition value="Palliative or debulking surgery."/>
</concept>
<concept>
<code value="SHA-BMT-AUTOLOGOUS"/>
<display value="SHA: BMT — Autologous"/>
<definition value="Autologous bone marrow / stem cell transplant."/>
</concept>
<concept>
<code value="SHA-BMT-ALLOGENEIC"/>
<display value="SHA: BMT — Allogeneic"/>
<definition value="Allogeneic bone marrow / stem cell transplant."/>
</concept>
<concept>
<code value="SHA-HORMONAL-THERAPY"/>
<display value="SHA: Hormonal Therapy"/>
<definition value="Hormone therapy for hormone-responsive cancers."/>
</concept>
<concept>
<code value="SHA-TARGETED-THERAPY"/>
<display value="SHA: Targeted Therapy"/>
<definition value="Targeted molecular therapy / immunotherapy."/>
</concept>
<concept>
<code value="SHA-SUPPORTIVE-CARE"/>
<display value="SHA: Supportive / Supportive Care"/>
<definition value="Supportive medications and G-CSF."/>
</concept>
<concept>
<code value="SHA-PAIN-MANAGEMENT"/>
<display value="SHA: Palliative Pain Management"/>
<definition value="Opioid and pain management for cancer."/>
</concept>
<concept>
<code value="SHA-CANCER-SCREENING"/>
<display value="SHA: Cancer Screening"/>
<definition value="Covered cancer screening tests (cervical, breast)."/>
</concept>
<concept>
<code value="SHA-BIOPSY"/>
<display value="SHA: Diagnostic Biopsy"/>
<definition value="Tissue biopsy for cancer diagnosis."/>
</concept>
<concept>
<code value="SHA-IMAGING"/>
<display value="SHA: Oncology Diagnostic Imaging"/>
<definition value="CT, MRI, PET-CT for staging or response."/>
</concept>
<concept>
<code value="SHA-ONCOLOGY-CONSULT"/>
<display value="SHA: Oncology Consultation"/>
<definition value="Specialist oncology consultation."/>
</concept>
<concept>
<code value="SHA-MDT"/>
<display value="SHA: MDT Meeting"/>
<definition value="Multidisciplinary tumour board review."/>
</concept>
<concept>
<code value="SHA-PATHOLOGY"/>
<display value="SHA: Pathology / Histopathology"/>
<definition value="Histopathology, IHC, or molecular diagnostics."/>
</concept>
<concept>
<code value="SHA-RT-DOSE-PER-FRACTION"/>
<display value="SHA: RT Dose Per Fraction"/>
<definition value="Radiation dose delivered per fraction (Gy)."/>
</concept>
<concept>
<code value="SHA-RT-TOTAL-FRACTIONS"/>
<display value="SHA: RT Total Fractions Delivered"/>
<definition value="Total number of radiation fractions delivered."/>
</concept>
<concept>
<code value="SHA-SUSPECTED-CANCER-TYPE"/>
<display value="SHA: Suspected Cancer Type"/>
<definition value="Type of cancer suspected at screening/referral."/>
</concept>
<concept>
<code value="SHA-SUSPICION-LEVEL"/>
<display value="SHA: Cancer Suspicion Level"/>
<definition value="Clinical level of suspicion for malignancy."/>
</concept>
<concept>
<code value="SHA-REASON-FOR-SUSPICION"/>
<display value="SHA: Reason for Suspicion"/>
<definition value="Reason underpinning the cancer suspicion."/>
</concept>
<concept>
<code value="SHA-PRESENTING-SYMPTOMS"/>
<display value="SHA: Presenting Symptoms"/>
<definition value="Symptoms presented by the patient."/>
</concept>
<concept>
<code value="SHA-DIAGNOSTIC-WORKUP"/>
<display value="SHA: Planned Diagnostic Workup"/>
<definition value="Diagnostic investigations planned for confirmation."/>
</concept>
</CodeSystem>